AD

Novel Therapeutics in Atopic Dermatitis
Novel Therapies Atopic Dermatitis
by Mojgan Hosseinipour, DO, FAAD on
Atopic dermatitis (AD) is a chronic inflammatory skin disease. The pathogenesis of AD is complex with many mediators involved and can be broken down into 4 categories: Immune dysregulation Abnormal skin barrier Abnormal itch/scratch cycle Abnormal skin microbiome In AD, there is a breakdown in molecular control of the immune system, leading to overproduction and expressi …
Dupilumab Therapeutic Cheat Sheet
Dupilumab
by Azam Qureshi, MD on
Atopic dermatitis (AD) is a common skin condition characterized by pruritus and occurs as a result of factors related to impaired skin barrier and immune response, as well as environmental and infectious agents. Patients with poor control on topical therapy are looking for safe and effective systemic treatments. We continue our series, Therapeutic Cheat Sheet, with a closer look at dupilumab, whic …
Lessons from the Skin Microbiome: Innate Immunity, Skin Disease, and COVID-19
skin microbiome
by Azam Qureshi, MD on
While I was beginning the process of “scrubbing in” to assist in the hemicolectomy case as an intern, I carefully squeezed the anti-septic chlorhexidine-soaked sponge and watched the brown solution drip its way down my forearms. I continued the ritual by cleaning under the fingernails and on every plane of the fingers, hands, and forearms multiple times. After all; “Clean Hands Save Lives, …
Easing the Management of Atopic Dermatitis
Atopic Dermatitis
by Jacqueline McKesey, MD MS on
Dr. Friedman, jack of many trades, Professor and Interim Chair of Dermatology at George Washington University provided an excellent overview of ways to achieve victory over atopic dermatitis (AD). This expert discussion took place during the ODAC Inflammatory Diseases Symposium on December 3, 2020. How could we possibly cover atopic dermatitis in 20 minutes? Well, Dr. Friedman skillfully led us …
SOCU 2020 Pearls Galore: AD, HS, Hair Care in SOC, and Medication Compliance Among Teens
HS, AD, Alopecia in SOC
by Shweta Shukla, MD on
The following is a summary of one of the many Q&A sessions held during the 2020 Skin of Color Virtual Update. During this particular session, questions were moderated by SOCU Co-Chair Dr. Andrew Alexis and answered by Drs. Ginette Okoye and Candrice Heath. The audience posed important questions and the faculty offered insightful answers regarding atopic dermatitis, hidradenitis suppurativa, h …